Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The value of continuous glucose monitoring in the management of type 1 diabetes mellitus has not been determined. METHODS: In a multicenter clinical trial, we randomly assigned 322 adults and children who were already receiving intensive therapy for type 1 diabetes to a group with continuous glucose monitoring or to a control group performing home monitoring with a blood glucose meter. All the patients were stratified into three groups according to age and had a glycated hemoglobin level of 7.0 to 10.0%. The primary outcome was the change in the glycated hemoglobin level at 26 weeks. RESULTS: The changes in glycated hemoglobin levels in the two study groups varied markedly according to age group (P=0.003), with a significant difference among patients 25 years of age or older that favored the continuous-monitoring group (mean difference in change, -0.53%; 95% confidence interval [CI], -0.71 to -0.35; P<0.001). The between-group difference was not significant among those who were 15 to 24 years of age (mean difference, 0.08; 95% CI, -0.17 to 0.33; P=0.52) or among those who were 8 to 14 years of age (mean difference, -0.13; 95% CI, -0.38 to 0.11; P=0.29). Secondary glycated hemoglobin outcomes were better in the continuous-monitoring group than in the control group among the oldest and youngest patients but not among those who were 15 to 24 years of age. The use of continuous glucose monitoring averaged 6.0 or more days per week for 83% of patients 25 years of age or older, 30% of those 15 to 24 years of age, and 50% of those 8 to 14 years of age. The rate of severe hypoglycemia was low and did not differ between the two study groups; however, the trial was not powered to detect such a difference. CONCLUSIONS: Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes. Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. (ClinicalTrials.gov number, NCT00406133.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large trial of rt-CGM in people with type 1 diabetes showing significant reductions in HbA 1c in adults (159), improved glucose control was not seen in children (ages 8 to 14 years) or adolescents and young adults (ages 15 to 24 years).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Most randomized controlled trials (RCTs) in adults with type 1 diabetes show that rt-CGM leads to lower HbA 1c (156-159) and reduced time in the hypoglycemic range (160,161).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Integration of continuous glucose monitoring (CGM) into the treatment plan soon after diagnosis improves glycemic outcomes, decreases hypoglycemic events, and improves quality of life for individuals with type 1 diabetes (18-23).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [22]
In the citing paper
“Tamborlane and colleagues91 reported that a real-time continuous glucose monitoring system decreased the amount of time spent in hypoglycaemia (<4 mmol/L [70 mg/dL]) and lowered HbA1C when used by patients an average of 6 days a week.”
From Type 1 diabetes (2014) · cites this paper as [91]
In the citing paper
“In this study, the degree of HbA1C reduction directly correlated with higher HbA1C concentrations before beginning continuous glucose monitoring.”
From Type 1 diabetes (2014) · cites this paper as [91]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Self-citationStandards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Self-citationEpidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Research works printed but not linked: 1
- Little RJA, Rubin DB. Statistical analysis with missing data. New York: John Wiley, 1987.
Cited by
Items 501–600 of 1,001
Penalty weighted glucose prediction models could lead to better clinically usage
Cichosz, S. L., Kronborg, T., Jensen, M. H., & Hejlesen, O. K. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104865 · Cited by 42
Giménez, M., Lara, M., & Conget, I. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0028 · Cited by 38
Glycemic Management in Adults With Type 1 Diabetes
McGibbon, A., Adams, L., Ingersoll, K. S., Kader, T., & Tugwell, B. D. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.012 · Cited by 58
Garg, S. K., & Aktürk, H. K. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0142 · Cited by 37
Hypoglycemia in older adults with type 1 diabetes
DuBose, S. N., Weinstock, R. S., Beck, R. W., Peters, A. L., Aleppo, G., Bergenstal, R. M., Rodriguez, H., Largay, J. F., Massaro, E. M., Hirsch, I. B., et al. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0268 · Cited by 36
Kim, J. Y., Jin, S.-M., Sim, K. H., Kim, B.-Y., Cho, J. H., Moon, J. S., Lim, S., Kang, E. S., Park, C.-Y., Kim, S. G., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06152-1 · Cited by 36
Davey, R. J., Jones, T. W., & Fournier, P. A. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400620 · Cited by 36
Rashotte, J., Tousignant, K. F., Richardson, C., Fothergill‐Bourbonnais, F., Nakhla, M. M., Olivier, P., & Lawson, M. L. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.02.002 · Cited by 41
González-Cava, J. M., Reboso, J. A., Casteleiro‐Roca, J., ROLLE, J. L. C., & Pérez, J. A. M. (2018) · Complexity · doi:10.1155/2018/9012720 · Cited by 36
Lee, W.-C., Gurudatt, N. G., Park, D., Kim, K. B., Choi, C. S., & Shim, Y. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.128416 · Cited by 36
Galindo, R. J., Parkin, C. G., Aleppo, G., Carlson, A. L., Kruger, D. F., Levy, C. J., Umpierrez, G. E., & McGill, J. B. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0107 · Cited by 38
Danne, T., de Valk, H. W., Kracht, T., Walte, K., Geldmacher, R., Sölter, L., Berge, W. V. D., Welsh, Z., Bugler, J., Lange, K., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1408-6 · Cited by 39
Fluorescence Intensity- and Lifetime-Based Glucose Sensing Using Glucose/Galactose-Binding Protein
Pickup, J. C., Khan, F., Zhi, Z., Coulter, J. A., & Birch, D. J. S. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700108 · Cited by 38
García‐Lorenzo, B., Rivero‐Santana, A., Vallejo‐Torres, L., Castilla‐Rodríguez, I., García‐Pérez, S., García‐Pérez, L., & Perestelo‐Pérez, L. (2018) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12987 · Cited by 39
Mastrototaro, J. J., & Lee, S. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0134 · Cited by 37
Raccah, D., Sulmont, V., Reznik, Y., Guerci, B., Renard, É., Hanaire, H. P., Jeandidier, N., & Nicolino, M. P. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)61016-2 · Cited by 36
Sparacino, G., Zanon, M., Facchinetti, A., Zecchin, C., Maran, A., & Cobelli, C. (2012) · Sensors · doi:10.3390/s121013753 · Cited by 37
Sherr, J. L., Palau Collazo, M., Cengiz, E., Michaud, C., Carria, L., Steffen, A. T., Weyman, K., Zgorski, M., Tichy, E., Tamborlane, W. V., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1608 · Cited by 35
Yu, X., Littlejohn, E., Quinn, L., Çınar, A., Rashid, M. M., Feng, J., Hobbs, N., Hajizadeh, I., Samadi, S., Sevil, M., et al. (2018) · IEEE Transactions on Control Systems Technology · doi:10.1109/tcst.2018.2843785 · Cited by 38
Oliver, N. S., Giménez, M., Calhoun, P. M., Cohen, N., Moscardó, V., Hermanns, N., Freckmann, G., Reddy, M., & Heinemann, L. (2019) · Diabetes Care · doi:10.2337/dc19-0977 · Cited by 39
MCVEAN, J. J. F., & Miller, J. D. (2021) · Expert Review of Medical Devices · doi:10.1080/17434440.2021.1926984 · Cited by 41
Mencher, S., WEINZIMER, S. A., Nally, L. M., Name, M. A. V., Nuñez-Smith, M., & Sadler, L. S. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0413 · Cited by 37
Management of Hypoglycemia in Children and Adolescents with Type 1 Diabetes Mellitus
McGill, D. E., & Levitsky, L. L. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0771-1 · Cited by 39
Continuous Glucose Monitoring in Youth with Type 1 Diabetes
Wadwa, R. P., Fiallo-Scharer, R. V., VanderWel, B., Messer, L. H., Cobry, E. C., & Chase, H. P. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0122 · Cited by 36
Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist
Bally, L., Thabit, H., & Hovorka, R. (2017) · BMC Medicine · doi:10.1186/s12916-017-0794-8 · Cited by 38
Automated Insulin Delivery for Young People with Type 1 Diabetes and Elevated A1c
Boucsein, A., Zhou, Y., Michaels, V. R., Haszard, J. J., Jefferies, C., Wiltshire, E. J., Paul, R. G., Parry‐Strong, A., Pasha, M., Petrovski, G., et al. (2024) · NEJM Evidence · doi:10.1056/evidoa2400185 · Cited by 38
A Multiple Local Models Approach to Accuracy Improvement in Continuous Glucose Monitoring
Barceló-Rico, F., Bondía, J., Díez, J.-L., & Rossetti, P. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0138 · Cited by 34
New technologies for diabetes: a review of the present and the future
Ramchandani, N., & Heptulla, R. A. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-28 · Cited by 48
Lunn, D. J., Wei, C., & Hovorka, R. (2011) · Statistics in Medicine · doi:10.1002/sim.4254 · Cited by 37
Piona, C., Dovc, K., Mutlu, G. Y., Grad, K., Gregorc, P., Battelino, T., & Bratina, N. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12729 · Cited by 34
“Comparable improvements in glycemic profile were demonstrated in a large randomized controlled trial comparing the use of rtCGM in pediatric patients with T1D and with HbA1c above 7% treated with insulin pump therapy.18 Results from previous trials and a post hoc analysis of frequent rtCGM users involved in the Juveni…”
ResultShort Sleep Duration Is Associated With a Blood Pressure Nondipping Pattern in Type 1 Diabetes
Borel, A., Benhamou, P., Baguet, J.-P., Debaty, I., Levy, P. A., Pépin, J., & Mallion, J.-M. (2009) · Diabetes Care · doi:10.2337/dc09-0422 · Cited by 36
Artificial pancreas: fuzzy logic and control of glycemia
Nimri, R., & Phillip, M. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000073 · Cited by 37
Welsh, J. B., Zhang, X., Puhr, S. A., Johnson, T. K., Walker, T. C., Balo, A. K., & Price, D. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818798816 · Cited by 33
The Future of Continuous Glucose Monitoring
Garg, S. K., & Akturk, H. K. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0097 · Cited by 34
Mariani, H., Layden, B. T., & Aleppo, G. (2017) · Clinical Diabetes · doi:10.2337/cd16-0008 · Cited by 38
Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians
Iqbal, A., Novodvorský, P., & Heller, S. R. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.3 · Cited by 45
Gal, R. L., Cohen, N. J., Kruger, D., Beck, R. W., Bergenstal, R. M., Calhoun, P., Cushman, T., Haban, A., Hood, K., Johnson, M. L., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa076 · Cited by 32
Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021
CHENG, A. Y. Y., Feig, D. S., Ho, J., Siemens, R. L., BAJAJ, H. S., Gilbert, J. D., Houlden, R. L., Kim, J., MacKay, D., Rabi, D. M., et al. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.07.003 · Cited by 38
Davis, G. M., Bailey, R. J., Calhoun, P. M., Price, D. A., & Beck, R. W. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0489 · Cited by 37
Benefits of Continuous Glucose Monitor Use in Clinical Practice
Leinung, M. C., Thompson, S., & Nardacci, E. (2009) · Endocrine Practice · doi:10.4158/ep09287.or · Cited by 33
Parsaik, A. K., Carter, R. E., Pattan, V., Myers, L. A., Kumar, H., Smith, S. A., Russi, C. S., Levine, J. A., Basu, A., & Kudva, Y. C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600109 · Cited by 33
Kovatchev, B. P. (2012) · Scientifica · doi:10.6064/2012/283821 · Cited by 39
Metabolic Management during Critical Illness: Glycemic Control in the ICU
Inzucchi, S. E., & Honiden, S. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1565253 · Cited by 36
Zhang, W., Liu, Y., Sun, B., Shen, Y., Li, M., Peng, L., Duan, H., Su, X., Lu, S., Tian, X., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03480-9 · Cited by 32
Utility of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes
Toschi, E., & Wolpert, H. A. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.003 · Cited by 41
Datye, K. A., Tilden, D. R., Parmar, A. M., Goethals, E. R., & Jaser, S. S. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01389-1 · Cited by 34
Biswas, T., Behera, B. K., & Madhu, N. R. (2023) · Springer eBooks · doi:10.1007/978-981-19-0027-3_6 · Cited by 35
Rodbard, D., Jovanovic, L., & Garg, S. K. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0078 · Cited by 32
Adaptive Calibration Algorithm for Plasma Glucose Estimation in Continuous Glucose Monitoring
Barceló-Rico, F., Díez, J.-L., Rossetti, P., Vehí, J., & Bondía, J. (2013) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2013.2253325 · Cited by 34
Closed-Loop Glucose Control: Psychological and Behavioral Considerations
Gonder-Frederick, L. A., Shepard, J. A., & Peterson, N. D. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500610 · Cited by 33
Continuous blood glucose monitoring in diabetes treatment
Vazeou, A. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70028-6 · Cited by 38
Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults
Sherr, J. L. (2018) · Diabetes Care · doi:10.2337/dci18-0003 · Cited by 35
Slover, R. H., Tryggestad, J. B., DiMeglio, L. A., Fox, L. A., Bode, B. W., Bailey, T. S., Brazg, R., Christiansen, M. P., Sherr, J. L., Tsalikian, E., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0109 · Cited by 31
Point-of-care testing technologies for the home in chronic kidney disease: a narrative review
Bodington, R., Kassianides, X., & Bhandari, S. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab080 · Cited by 37
Soni, A., Wright, N. P., Agwu, J. C., Timmis, A., Drew, J., Kershaw, M., Moudiotis, C., Regan, F. M., Williams, E., Wan, J., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109196 · Cited by 35
Treatment of type 1 diabetes in children and adolescents using modern insulin pumps
Kordonouri, O., Hartmann, R., & Danne, T. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70027-4 · Cited by 35
Practical Aspects of Real-Time Continuous Glucose Monitoring
Gilliam, L. K., & Hirsch, I. B. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0135 · Cited by 34
Hypo- and Hyperglycemic Alarms: Devices and Algorithms
Howsmon, D. P., & Bequette, B. W. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815583507 · Cited by 35
Current Trends in Continuous Glucose Monitoring
Lodwig, V., Kulzer, B., Schnell, O., & Heinemann, L. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814525826 · Cited by 33
Ajjan, R. A., Abougila, K., Bellary, S., Collier, A., Franke, B., Jude, E. B., Rayman, G., Robinson, A., & Singh, B. M. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115624680 · Cited by 30
Feig, D. S., & Murphy, H. R. (2018) · Diabetic Medicine · doi:10.1111/dme.13585 · Cited by 35
Klonoff, D. C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600301 · Cited by 36
Ren, H., Coughlin, M. A., Major, T. C., Aiello, S., Rojas Pena, A., Bartlett, R. H., & Meyerhoff, M. E. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b01590 · Cited by 30
Benefits and limitations of continuous glucose monitoring in type 1 diabetes
Stone, J. Y., & Bailey, T. S. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1706482 · Cited by 30
Scaramuzza, A. E., Iafusco, D., Rabbone, I., Bonfanti, R., Lombardo, F., Schiaffini, R., Buono, P., Toni, S., Cherubini, V., & Zuccotti, G. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0119 · Cited by 30
The Accuracy Benefit of Multiple Amperometric Glucose Sensors in People With Type 1 Diabetes
Castle, J. R., Pitts, A., Hanavan, K., Muhly, R., Youssef, J. E., Karvetski, C., Kovatchev, B. P., & Ward, W. K. (2012) · Diabetes Care · doi:10.2337/dc11-1929 · Cited by 32
Personal Versus Professional Continuous Glucose Monitoring: When to Use Which on Whom
Longo, R. R., & Sperling, S. B. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0093 · Cited by 32
Sun, K., Ding, Z., Zhang, J., Chen, H., Qin, Y., Xu, S., Wu, C., Yu, J., & Chiu, D. T. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001019 · Cited by 31
Mathias, P., Mahali, L. P., & Agarwal, S. (2022) · Diabetes Care · doi:10.2337/dc22-0555 · Cited by 33
Hyperglycemia, Hypoglycemia and Dementia: Role of Mitochondria and Uncoupling Proteins
Cardoso, S., Correia, S. C., Santos, R. X., Carvalho, C., Candeias, E., Duarte, A. I., Plácido, A. I., Santos, M. S., & Moreira, P. I. (2013) · Current Molecular Medicine · doi:10.2174/1566524011313040010 · Cited by 33
Continuous glucose monitoring: current clinical use
Kim, H., Shin, J., Chang, J., Cho, J., Son, H., & Yoon, K. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2346 · Cited by 33
Unblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes
Ahn, D. T., Pettus, J., & Edelman, S. V. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816632241 · Cited by 31
“Meanwhile, real-time CGM has been consistently proven to reduce frequency and time spent in hypoglycemia.(1-4)”
BackgroundInfluentialFrontino, G., Bonfanti, R., Scaramuzza, A. E., Rabbone, I., Meschi, F., Rigamonti, A., Battaglino, R., Favalli, V., Bonura, C., Sicignano, S., et al. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0044 · Cited by 29
Picard, S., Hanaire, H. P., Baillot-Rudoni, S., Bonnemaison, É., Not, D., Reznik, Y., & Guerci, B. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0240 · Cited by 29
Salient Characteristics of Youth with Type 1 Diabetes Initiating Continuous Glucose Monitoring
Teló, G. H., Volkening, L. K., Butler, D. A., & Laffel, L. M. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0290 · Cited by 31
McAuley, S. A., de Bock, M. I., Sundararajan, V., Lee, M. H., Paldus, B., Ambler, G. R., Bach, L. A., Burt, M. G., Cameron, F. J., Clarke, P., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020274 · Cited by 29
“At the end of the run-in period, the CGM data will be uploaded and checked to ensure data are available for at least 70% of the time.(40) If the minimum required CGM data are not available, an additional week of CGM will be undertaken to fulfil the protocol requirements.”
MethodA systematic review on clinical implication of continuous glucose monitoring in diabetes management
Gillani, S. W., Azhar, A., Mohiuddin, G., & Majeed, R. A. (2020) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_7_20 · Cited by 35
Flash Glucose Monitoring and Patient Satisfaction: A Meta-Review of Systematic Reviews
Díez‐Fernández, A., Rodríguez‐Huerta, M. D., González, R. M., Laredo‐Aguilera, J. A., & Espinosa, N. M. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18063123 · Cited by 33
Adolfsson, P., Örnhagen, H., & JENDLE, J. H. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0017 · Cited by 31
Jenkins, A. J., Krishnamurthy, B., Best, J. D., Cameron, F. J., Colman, P. G., Farish, S., Hamblin, P. S., O’Connell, M. A., Rodda, C. P., Rowley, K., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1481 · Cited by 29
A ‘radical’ new rural model for pediatric diabetes care
Goss, P. W., Paterson, M. A., & Renalson, J. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00594.x · Cited by 29
Devices for continuous monitoring of glucose: update in technology
Gómez, A. M., Carrillo, D. C. H., & Múñoz, Ó. (2017) · Medical Devices Evidence and Research · doi:10.2147/mder.s110121 · Cited by 35
Giménez, M., Tannen, A. J., Reddy, M., Moscardó, V., Conget, I., & Oliver, N. S. (2017) · Diabetes Care · doi:10.2337/dc17-1597 · Cited by 35
Kumagai, R., Muramatsu, A., Fujii, M., Katakura, Y., Ito, K., Fujie, K., Nakata, Y., Hashimoto, K., & Yagyu, H. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12970 · Cited by 32
Minder, A. E., Albrecht, D., Schäfer, J., & Zulewski, H. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.024 · Cited by 28
Joshi, M., & Choudhary, P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0644-z · Cited by 32
Ruedy, K. J., & Tamborlane, W. V. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9364-9 · Cited by 32
Thabit, H., Elleri, D., Leelarathna, L., Allen, J. M., Lubina-Solomon, A., Stadler, M., Walkinshaw, E., Iqbal, A., Choudhary, P., Wilinska, M. E., et al. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12427 · Cited by 31
“Ado-lescents appear to benefit less, owing to a reduction in time when the glucose sensor was used [20].”
BackgroundPediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology
Ravi, S., Coakley, A., Vigers, T., Pyle, L. L., Forlenza, G. P., & Alonso, T. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820906214 · Cited by 29
Vinoth, V., Pugazhenthiran, N., Mangalaraja, R. V., Syed, A., Marraiki, N., Váldes, H., & Anandan, S. (2020) · The Analyst · doi:10.1039/d0an01526a · Cited by 29
Bent, B., Henriquez, M., & Dunn, J. (2021) · IEEE Open Journal of Engineering in Medicine and Biology · doi:10.1109/ojemb.2021.3105816 · Cited by 29
Kumareswaran, K., Elleri, D., Allen, J. M., Harris, J., Xing, D., Kollman, C., Nodale, M., Murphy, H. R., Amiel, S. A., Heller, S. R., et al. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500606 · Cited by 31
Zecchin, C., Facchinetti, A., Sparacino, G., Man, C. D., Manohar, C. U., Levine, J. A., Basu, A., Kudva, Y. C., & Cobelli, C. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0105 · Cited by 28
Little, S., Chadwick, T., Choudhary, P., Brennand, C., Stickland, J., Barendse, S., Olateju, T., Leelarathna, L., Walkinshaw, E., Tan, H. K., et al. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-33 · Cited by 27
Juvenile Diabetes Research Foundation Artificial Pancreas Consortium Update
Kowalski, A. J., & Lum, J. W. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300531 · Cited by 31
Yeoh, E., Lim, B. K., Fun, S., Tong, J., Yeoh, L. Y., Sum, C. F., Subramaniam, T., & Lim, S. C. (2018) · Nephrology · doi:10.1111/nep.12978 · Cited by 27
Clinical Use of Continuous Glucose Monitoring in Pediatrics
Lal, R., & Maahs, D. M. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0013 · Cited by 31
Shukla, V., Fuchs, P., Liu, A., Cohan, C. H., Dong, C., Wright, C. B., Pérez‐Pinzón, M. A., & Dave, K. R. (2018) · Translational Stroke Research · doi:10.1007/s12975-018-0622-2 · Cited by 30
Hansen, E. A., Klee, P., Dirlewanger, M., Bouthors, T., Elowe-Gruau, É., Stoppa‐Vaucher, S., Phan-Hug, F., Antoniou, M.-C., Pasquier, J., Dwyer, A. A., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12723 · Cited by 31
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Pehrsson, N.-G., & Moström, P. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816642578 · Cited by 27
Metadata
- Authors
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Affiliations
- Yale University (US)
- Corresponding author
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-02
- Volume
- 359
- Issue
- 14
- Pages
- 1464-1476
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1531505795
- Semantic Scholar
- b1462f3524589cf66909ea165b57d41352a0293b
- Cited by
- 1,559
- References
- 30
- Citations by year
- 2026: 29 · 2025: 60 · 2024: 64 · 2023: 54 · 2022: 61 · 2021: 103 · 2020: 104 · 2019: 90 · 2018: 109 · 2017: 101 · 2016: 95 · 2015: 85 · 2014: 79 · 2013: 86 · 2012: 104
- FWCI
- 79.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, intensive insulin therapy, HbA1c, glycemic control, age differences, children and adolescents, severe hypoglycemia
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Insulin Infusion Systems, Male, Blood Glucose Self-Monitoring, Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.